Effect of a hearing loss care education program for older adults targeted at visiting nurses: A cluster randomized controlled trial. [PDF]
Nabeshima S +4 more
europepmc +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Experiences of Ageism in mHealth App Usage Among Older Adults: Interview Study Among Older Adults Based on Extended Unified Theory of Acceptance and Use of Technology and Risks of Ageism Models. [PDF]
Sun J +5 more
europepmc +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Social inclusion among young adults with mental illness and complex needs in Flexible Assertive Community Treatment: A qualitative study on team staff's understanding and experiences. [PDF]
Nord-Baade S +4 more
europepmc +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Differential gastrointestinal mortality in Native Hawaiian/Pacific Islander and Asian subgroups in the U.S.: a cross-sectional analysis of national mortality surveillance data 2018-2023. [PDF]
Zhang TP, Dodge JL, Terrault NA, Lee BP.
europepmc +1 more source
Correlation between the gut microbiota composition and cognitive frailty: a case-control study in community-dwelling older adults. [PDF]
Wen N, Zhang Y, Sun L, He J, Zheng G.
europepmc +1 more source

